Antiretroviral therapy coverage for PMTCT in Congo

Congo: Antiretroviral therapy coverage for PMTCT was 42.0% in 2024. ◆ Volatile

Latest (2024)
42.0%
Change on year
up 31.2%
World rank
70th
of 84 countries
All-time high
42.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage for PMTCT in Congo, 2000–2024

0102030402000201220242000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 2 % of pregnant women living with HIV2003: 3 % of pregnant women living with HIV2004: 5 % of pregnant women living with HIV2005: 4 % of pregnant women living with HIV2006: 5 % of pregnant women living with HIV2007: 9 % of pregnant women living with HIV2008: 16 % of pregnant women living with HIV2009: 8 % of pregnant women living with HIV2010: 10 % of pregnant women living with HIV2011: 23 % of pregnant women living with HIV2012: 19 % of pregnant women living with HIV2013: 24 % of pregnant women living with HIV2014: 20 % of pregnant women living with HIV2015: 19 % of pregnant women living with HIV2016: 11 % of pregnant women living with HIV2017: 12 % of pregnant women living with HIV2018: 8 % of pregnant women living with HIV2019: 8 % of pregnant women living with HIV2020: 14 % of pregnant women living with HIV2021: 24 % of pregnant women living with HIV2022: 23 % of pregnant women living with HIV2023: 32 % of pregnant women living with HIV2024: 42 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

Congo recorded 42.0% for antiretroviral therapy coverage for pmtct in 2024. That is the highest value across all 25 years on record.

The figure is up 31.2% on the previous year and up 110.0% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Congo peaked at 42.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places Congo 70th out of 84 countries with data for 2024, putting it in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Congo, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Congo, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 0.0%
2001 0.0%
2002 2.0%
2003 3.0% +50.0%
2004 5.0% +66.7%
2005 4.0% -20.0%
2006 5.0% +25.0%
2007 9.0% +80.0%
2008 16.0% +77.8%
2009 8.0% -50.0%
2010 10.0% +25.0%
2011 23.0% +130.0%
2012 19.0% -17.4%
2013 24.0% +26.3%
2014 20.0% -16.7%
2015 19.0% -5.0%
2016 11.0% -42.1%
2017 12.0% +9.1%
2018 8.0% -33.3%
2019 8.0% +0.0%
2020 14.0% +75.0%
2021 24.0% +71.4%
2022 23.0% -4.2%
2023 32.0% +39.1%
2024 42.0% +31.2%

Congo compared with similar countries

  • Congo's 42.0% is below the median for lower middle income countries, which is 83.5%, 50% of the median. (32 countries reporting)
  • Congo's 42.0% is below the median for Sub-Saharan Africa, which is 82.0%, 51% of the median. (41 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2000s 5.2% 0.0% 16.0% 10
2010s 15.4% 8.0% 24.0% 10
2020s 27.0% 14.0% 42.0% 5

Countries ranked near Congo

  1. 67 Paraguay 52.0% compare
  2. 68 Mali 46.0% compare
  3. 69 Somalia 43.0% compare
  4. 70 Costa Rica 42.0% compare
  5. 70 Honduras 42.0% compare
  6. 73 Mauritania 39.0% compare

See the full ranking of 99 places →

More health data for Congo

All data for Congo →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Congo?
Antiretroviral therapy coverage for pmtct in Congo was 42.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Congo?
The highest recorded value was 42.0% in 2024.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Congo?
The lowest recorded value was 0.0% in 2000.
How does Congo rank for antiretroviral therapy coverage for pmtct?
Congo ranks 70th out of 84 countries with data for 2024.
Is antiretroviral therapy coverage for pmtct rising or falling in Congo?
Over the last ten years it is up 110.0%. The long-run trend across the full record is volatile.
Where does this Congo data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Congo. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 16 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/congo-rep/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/congo-rep/">Antiretroviral therapy coverage for PMTCT in Congo</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).